Abdolhossen Talebian - Herndon VA Dianna C. Green - Falls Church VA Charles F. Hammer - Washington DC Philip S. Schein - Bryn Mawr PA
Assignee:
Georgetown University - Washington DC
International Classification:
C07H 1500 C07H 2300
US Classification:
536 171
Abstract:
Platinum compounds of the formulae: ##STR1## are disclosed. Compositions containing these compounds and methods of using the same in the treatment of tumors are also discussed.
Platinum Compounds Suitable For Use As Pharmaceuticals
Abdolhossen Talebian - Herndon VA Dianna C. Green - Falls Church VA Charles F. Hammer - Washington DC Philip S. Schein - Bryn Mawr PA
Assignee:
Georgetown University - Washington DC
International Classification:
A61K 3128 A61K 3170 C07H 2300
US Classification:
536121
Abstract:
Compounds of the formula: ##STR1## wherein each of R. sub. 1 and R. sub. 2 is independently selected from the group consisting of halogen, hydroxy, or mono carboxylic acid or R. sub. 1 and R. sub. 2 together is a multifunctional carboxylic acid residue which forms a ring with the platinum atom through two oxygens of said multifunctional carboxylic acid; R. sub. 3 is a deoxy mono or disaccharide or a derivative thereof; and R. sub. 4 is selected from the group consisting of hydrogen, C. sub. 1-4 -alkyl, phenyl, benzyl, substituted phenyl or substituted benzyl, wherein substituents are selected from the group consisting of halogen, nitro, C. sub. 1-2 -alkoxy, carboxy, carbony ester or phenyl or a pharmaceutically acceptable salt thereof are disclosed. Compositions containing these compounds and methods using these compounds are also discussed.
Abdolhossen Talebian - Herndon VA Dianna C. Green - Falls Church VA Philip S. Schein - Bryn Mawr PA
Assignee:
Georgetown University - Washington DC
International Classification:
C07H 1500 C07H 2300
US Classification:
536 171
Abstract:
Platinum compounds useful in the treatment of cancer are disclosed. Compositions containing these compounds and methods of using the same are also discussed. The compound have the formula: ##STR1## wherein n is 0 or 1, R. sub. 1 is selected from the group consisting of hydrogen, a mono or disaccharide or a derivative thereof linked to the nitrogen atom by a --NHCO-amide moiety, an --NHCS-- thioamide moeity or a --CO-- carbonylmoiety, R' is selected from the group consisting of hydrogen and C. sub. 1-4 alkyl, and R. sub. 2 and R. sub. 3 are selected from the group consisting of hydrogen, C. sub. 1-4 alkyl or R. sub. 2 and R. sub. 3 or R. sub. 2 and R. sub. 3 together are linked to adjacent carbon atoms on a four, five or six membered ring structure, or R. sub. 2 and R. sub. 3 together form a fused or bicyclic ring with adjacent carbon atoms; with the proviso that R' and R. sub. 1 cannot both be hydrogen when n=o, or a pharmaceutically acceptable salt thereof.
Mitomycin Derivatives Having Reduced Bone Marrow Toxicity, Processes For Their Preparation, And The Uses Thereof
Abdolhossen Talebian - Herndon VA Dianna Green - Falls Church VA Charles Hammer - Washington DC Philip Schein - Bryn Mawr PA Alem Ghiorghis - Washington DC Robert R. Clarke - Bethesda MD
Assignee:
Georgetown University - Washington DC
International Classification:
A61K 3140 A61K 2100 C07D48714
US Classification:
536 173
Abstract:
The invention relates to certain derivatives of mitomycins A and C and the use thereof to treat bacterial infections and to supress the growth of cancer cells. The invention also relates to processes for the preparation of the mitomycin derivatives of the invention.
Abdolhossen Talebian - Herndon VA Dianna C. Green - Falls Church VA Philip S. Schein - Bryn Mawr PA
Assignee:
Georgetown University - Washington DC
International Classification:
C07H 1500 C07H 2300
US Classification:
536121
Abstract:
Platinum compounds useful in the treatment of cancer are disclosed. Compositions containing these compounds and methods of using the same are also discussed. Compounds having the formula ##STR1## wherein n is 0 or 1 and when n is 1 R. sub. 1 is H or C. sub. 1 -C. sub. 4 alkyl, R is non-substituted higher alkyl or mono or disaccharide or a derivative of a mono or disaccharide, when n is O, R. sub. 1 is H or C. sub. 1 -C. sub. 4 alkyl, R is H, halogen, non-substituted C. sub. 1 -. sub. 20 alkyl, aryl, arlalkyloxy, mono or disaccharide, or a derivative of a mono or disaccharide, and R. sub. 2 and R. sub. 3 are selected from the group consisting of hydrogen, C. sub. 1. sup. -4 alkyl or R. sub. 2 and R. sub. 3 or R. sub. 2 and R. sub. 3 together are linked to adjacent carbon atoms on a four, five or six membered ring structure, or R. sub. 2 and R. sub.